Veradermics, Incorporated (MANE)
Veradermics, Incorporated (MANE) is a healthcare company (biotechnology) based in the United States. The share price is $126.48, down 1.23% on the day, which values the company at $5.34B. Price as of 17 Nov 2026, 17:42 UTC, from Yahoo Finance.
Key facts
- Share price
- $126.48−1.23% today
- Market value
- $5.34B
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Veradermics, Incorporated in more detail
MANE trades at -49.0× next year's expected earnings.
In its favour: More cash than debt.
2 of the superinvestors tracked here hold MANE, including Lee Ainslie (0.9% of the portfolio), Andreas Halvorsen (0.5% of the portfolio).
Superinvestors holding MANE
2 of the investors tracked here report a position in their latest 13F filing.
- Lee Ainslie Maverick Capital0.88% of portfolio · $97.1M · new · Q2 2026
- Andreas Halvorsen Viking Global Investors0.55% of portfolio · $192M · trimmed · Q2 2026
Health Care companies of similar size
- Lantheus HoldingsLNTH
- RadNetRDNT
- Belite BioBLTE
- Ligand PharmaceuticalsLGND
- Scholar Rock HoldingSRRK
- TeleflexTFX
- Mirum PharmaceuticalsMIRM
- GrifolsGRFS
- Cogent BiosciencesCOGT
- GRAILGRAL
- LifeStance Health GroupLFST
- BillionToOneBLLN
Side by side:MANE vs MIRM (Veradermics, Incorporated vs Mirum Pharmaceuticals)MANE vs GRFS (Veradermics, Incorporated vs Grifols)MANE vs TFX (Veradermics, Incorporated vs Teleflex)MANE vs SRRK (Veradermics, Incorporated vs Scholar Rock Holding)MANE vs COGT (Veradermics, Incorporated vs Cogent Biosciences)
All health care companies by market valueLargest companies in the United StatesAll stocks A–Z
Veradermics, Incorporated (MANE): questions and answers
What is Veradermics, Incorporated's market cap?
Veradermics, Incorporated is valued at $5.34B at a share price of $126.48.
Does MANE pay a dividend?
Veradermics, Incorporated does not currently pay a regular dividend.
Which famous investors own MANE?
In their latest quarterly filings, Lee Ainslie (0.9% of the portfolio), Andreas Halvorsen (0.5% of the portfolio) hold MANE. These filings are published up to 45 days after each quarter ends, so positions may have changed since.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Veradermics, Incorporated (MANE) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/MANE
Underlying data: Yahoo Finance; company filings with the SEC.